Inovio Pharmaceuticals
INO
#9619
Rank
HK$0.78 B
Marketcap
HK$9.57
Share price
2.52%
Change (1 day)
-8.35%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : HK$78.58 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is HK$78.58 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$92.11 M-60.96%
2023-12-31HK$0.23 B-5.85%
2022-12-31HK$0.25 B-2.68%
2021-12-31HK$0.25 B-14.94%
2020-12-31HK$0.30 B-60.94%
2019-12-31HK$0.77 B
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31HK$93.93 M0.38%
2008-12-31HK$93.57 M
2003-12-31HK$2.56 M1494.59%
2002-12-31HK$0.16 M-57.1%
2001-12-31HK$0.37 M
2001-03-31HK$0.91 M-0.6%
2000-03-31HK$0.92 M18.88%
1999-03-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.26 B 548,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$368.60 B 468,932.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$499.83 B 635,915.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$173.91 B 221,192.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$385.22 B 490,079.84%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$197.92 B 251,755.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$7.76 B 9,774.64%๐Ÿ‡บ๐Ÿ‡ธ USA